开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2023-04-18 1881f9877am 来自江苏省

审稿速度:1.0
偏重的研究方向：感染免疫
经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……

114 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2020-10-16 sunyini_1006

审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0
偏重的研究方向：脓毒症;免疫
经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。

200 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2022-01-24 122c13f7m51(暂无昵称)

审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0
偏重的研究方向：过敏
经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快

122 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2022-09-10 osmataku

需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了

114 0

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

摘要需要详细到什么程度？

145 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2021-12-27 衣谷

摘要一般控制在多少字符以内？

134 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2021-12-10 雪山飞蚊

偏重的研究方向：脓毒症
经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。

139 0

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2016-02-22 惜名

审稿速度:2.0
经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。

373 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2021-10-22 scarecrowly

最近投稿系统怎么总打不开？哪位老师知道？

130 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2126721, encodeId=c24a2126e21f1, content=审稿速度:1.0 偏重的研究方向：感染免疫 经验分享：4.13投稿，4.18送审，目前一个月没有消息，等待中……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/11/90003996080688d3e800d510119324ef.jpg, createdBy=7ecc2115349, createdName=1881f9877am, createdTime=Tue Apr 18 12:24:34 CST 2023, time=2023-04-18, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=892377, encodeId=b5be8923e73a, content=审稿速度:1.0 | 投稿命中率:25.0 | 审稿费用:50.0 偏重的研究方向：脓毒症;免疫 经验分享：5月22号投稿，6月12号一审回来大修，补了三个月实验，9月12号返回，一个月直接接收，Reviewers很认真，提的意见很中肯，按意见改好后就直接接收了，效率还是很高的。作为免疫学老牌杂志，是个非常值得一试的好杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa621330707, createdName=sunyini_1006, createdTime=Fri Oct 16 08:20:38 CST 2020, time=2020-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187612, encodeId=4a33118e612c7, content=审稿速度:1.0 | 投稿命中率:75.0 | 审稿费用:50.0 | 版面费用:5000.0 偏重的研究方向：过敏 经验分享：审稿速度很快，2个review提了很多问题，给了9个月修稿，认认真真补了2个月提交后很快就接收了。速度相当快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=40d92356557, createdName=122c13f7m51(暂无昵称), createdTime=Mon Jan 24 09:18:12 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248260, encodeId=07631248260c2, content=需要审稿费，影响因子不高，命中率也不高，只剩下老牌期刊的招牌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Sat Sep 10 09:08:54 CST 2022, time=2022-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093371, encodeId=eec210933e125, content=摘要需要详细到什么程度？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1093372, encodeId=6c6910933e279, content=摘要一般控制在多少字符以内？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078825, encodeId=244310e882553, content=偏重的研究方向：脓毒症 经验分享：一审39天，大修，给9个月的修稿时间。补了实验后投回去，3周后直接接收。效率还是比较满意的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Fri Dec 10 17:10:12 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=519403, encodeId=bfa45194036c, content=审稿速度:2.0 经验分享：2015年12月14日投了篇文章到CE版块，因为觉得数据量较少。12月31日拒稿，2个审稿人，提了很多问题。editor在拒稿意见中说，CE拒稿并不意味不可以投full length（客套话）。我大修了文章，2月3日投至full length，2月22日仍旧是“under review”。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=373, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28331664840, createdName=惜名, createdTime=Mon Feb 22 15:05:00 CST 2016, time=2016-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062976, encodeId=64c510629e6a4, content=最近投稿系统怎么总打不开？哪位老师知道？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=086d58616, createdName=scarecrowly, createdTime=Fri Oct 22 16:10:18 CST 2021, time=2021-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582304, encodeId=56a2582304c3, content=你好，你一审多久1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, beContent=1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=250, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=593b5210076, createdName=1475a490m80暂无昵称, createdTime=Sat Dec 28 00:00:00 CST 2019, time=2019-12-28, status=1, ipAttribution=)]

2019-12-28 1475a490m80暂无昵称

你好，你一审多久1253095392_18685667 2019-09-04 发表::
小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？1253095392_18685667 2019-09-04 00:00:00 发表:
小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？

1253095392_18685667 2019-09-04 发表:: 小修修回后第二天，杂志发邮件说 consideration for publication in The Journal of Immunology. 这是什么意思？还是要再审吗？

250 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务